Navigation Links
Proteome atlas for the tuberculosis pathogen
Date:5/17/2013

This news release is available in German.

Photographers know the problem all too well: with the naked eye, you can see which branch a bird is sitting on, but spotting the bird in the blur of branches through the telephoto lens for high-magnification images requires considerable skill. It is a similar story for researchers who are looking to study proteins, the active biomolecules of cells.

Olga Schubert, a doctoral student at ETH Zurich's Institute for Molecular Systems Biology, and her colleagues have now come up with a search aid. In order to help scientists to find a particular protein in the jumble of all other proteins (the proteome), they have produced a proteome atlas for the tuberculosis pathogen Mycobacterium tuberculosis, which they present in the latest issue of Cell Host & Microbe.

Like finding a needle in a haystack

Instead of a camera, scientists use a so-called mass spectrometer to measure proteins, which enables them to either record the overall image of the proteome or zoom in on particular sections to measure individual proteins precisely. However, for Selected Reaction Monitoring (SRM) close-ups with a telephoto lens researchers have to feed coordinates into the mass spectrometer so that it can find the selected protein in the tangle of thousands of other proteins.

Until now, scientists have had to determine the SRM coordinates for every single protein themselves, for instance when they want to study a specific biological process in the Mycobacterium. Schubert and her colleagues have made the search for the proverbial needle in a haystack easier by determining the coordinates for all the proteins of the tuberculosis pathogen. Using this new "reference work", scientists can now directly zoom in on the right spot on the proteome map.

97% of all tuberculosis proteins covered

In order to produce this resource, the team of researchers initially analysed the entire tuberculosis proteome. In doing so, they cut the proteins isolated from the Mycobacterium into many small pieces, so-called peptides, and measured them using the mass spectrometer. For every protein, they then singled out representative peptides that produced the clearest signal. They synthesised over 17,000 peptides in all and produced SRM measurement profiles for every individual piece of protein, thereby covering around 97 % of the roughly 4,000 tuberculosis proteins described. The key data of these profiles now serve as a guide to aid other scientists in finding every single protein of the pathogen.

With their overall analysis of the proteome, Schubert and her colleagues achieved such a high resolution that they even discovered previously unknown proteins, managing to add twenty-two new ones to the list of tuberculosis proteins. "Although the genome sequence of the mycobacterium has long been known, we haven't been able to decode the entire proteome yet," explains Schubert.

May aid new therapies and early detection

Researchers focus on the proteins of pathogens as they constitute the main target for new medication. Tuberculosis is still regarded as a dangerous disease, especially for patients with a weakened immune system, and multi-resistant strains of the bacteria that no longer respond to medication are increasingly becoming a problem. The classic search for new pharmaceutical products by combing through known substances for an antibacterial agent has not been as successful as expected. Scientists hope that basic research will produce results that might uncover new weak points for medication to attack. The tuberculosis proteome atlas could go a long way towards achieving this.

The coordinates recorded in it are so specific that tuberculosis proteins could also be traced in a complex mixture of proteins, such as in a patient blood or tissue sample. As a result, this data could also help researchers to develop better diagnostic methods to detect an infection as early as possible.

Researchers under Ruedi Aebersold, professor of molecular systems biology at ETH Zurich and the University of Zurich, have already produced a similar proteome atlas for the model organism yeast. Other organisms, especially pathogens, could follow suit and aid the development of new treatments.


'/>"/>

Contact: Olga Schubert
schubert@imsb.biol.ethz.ch
41-446-332-105
ETH Zurich
Source:Eurekalert

Related biology technology :

1. Quadrant Engineering Plastic Products Assigns Production of Acetron® GP and Nylon 101 Hex/Square Rods to Atlas Fibre Company
2. Cancer Antibodies: Drug Target Atlas and Competitive Outlook
3. Roka Bioscience Kicks Off Atlas on Tour, a Mobile Demonstration Vehicle for the Food Safety Industry, at IAFP
4. Tuberculosis Immunotherapy Grant for Immunoxel Honibe Honey Lozenges
5. Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
6. From the mouths of monkeys: Swab technique spots tuberculosis in non-human primates
7. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
8. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
9. PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing
10. PathoGenetix and FDA to Evaluate Bacterial Identification System for Use in FDA Public Health and Food Safety Efforts
11. Venter Institute-Led Team Recovers and Sequences Genome of Periodontal Pathogen from Biofilm in Hospital Sink using Single-Cell Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. ... Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate ... U.K. Biobank resource. The initiative will enable researchers to gain ... medicines for a wide range of serious and life threatening ... ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOGĀ“s multi-biometrics ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
Breaking Biology News(10 mins):